Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Rigaku Wins Order for a TXRF 450mm Spectrometer
Friday, February 14, 2014
Company wins order from a global Semiconductor Equipment Manufacturer.

Rigaku Publishes New Method for Analysis of Iron, Calcium and Silicon Oxides
Friday, February 14, 2014
Analysis of iron in EAFS by using the Rigaku NEX QC+ EDXRF analyzer.

PANalytical’s Epsilon 3X Benchtop Spectrometers at AXAA Conference
Tuesday, February 11, 2014
New Epsilon 3X benchtop spectrometers provide ultimate light-element performance.

PANalytical’s Epsilon 3X Benchtop Spectrometers Outperform Light-element Analysis
Monday, February 10, 2014
The spectrometers deliver outstanding analytical performance right across the periodic table.

New Article by Spinnovation Biologics’ CEO Frederic Girard
Friday, February 07, 2014
New article details NMR for Quality by Design biologics development.

Shimadzu's New EDX Fluorescence Spectrometers
Friday, January 31, 2014
Achieve precise, high-sensitivity analysis of a wide range of elements.

Calibrated Glass and Oil Standards for Glass Refractive Index Measurements
Wednesday, January 29, 2014
CRAIC Technologies announces the availability of glass and oil standard reference materials set to calibrate glass refractive index measurement instruments.

Energetiq Technology; Enhanced Performance EQ-99X-Series Laser-Driven Light Sources
Wednesday, January 29, 2014
The Laser-Driven Light Sources are introduced at Photonics West 2014.

Shimadzu Announces Product Launches, Presentations and Poster Sessions for Pittcon
Thursday, January 23, 2014
SSI at Pittcon 2014 conference and exhibition, March 2-6, at McCormick Place in Chicago.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 515
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv